The Safety and Dosimetry Study of 177Lu-LNC1003 Injection

Clinical trial NCT06237491 · UNKNOWN

Trial details

NCT number: NCT06237491
Sponsor: Yantai LNC Biotechnology Singapore PTE. LTD.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Castration-resistant Prostate Cancer, mCRPC

Start date: 2025-05-07
Primary completion: 2025-11-07
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.